|
Jul 10
|
Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca
|
|
Jul 10
|
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
|
|
Jul 10
|
AbbVie names new R&D head; Arcutis eczema cream approved
|
|
Jul 8
|
The Smartest Dividend Stocks to Buy With $250 Right Now
|
|
Jul 2
|
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
|
|
Jul 2
|
AbbVie to Host Second-Quarter 2024 Earnings Conference Call
|
|
Jul 1
|
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
|
|
Jul 1
|
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
|
|
Jul 1
|
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
|
|
Jul 1
|
3 Magnificent Stocks Retirees Can Buy and Hold Forever
|
|
Jul 1
|
10 clinical trials to watch in the second half of 2024
|
|
Jun 29
|
How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
|
|
Jun 28
|
How Medicare drug price negotiations could hit pharma stocks
|
|
Jun 28
|
Coherus offloads Humira biosimilar Yusimry for $40m
|
|
Jun 28
|
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
|
|
Jun 28
|
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
|
|
Jun 28
|
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
|
|
Jun 28
|
AbbVie completes acquisition of Celsius Therapeutics for $250m
|
|
Jun 28
|
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
|
|
Jun 27
|
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
|